Ardelyx (NASDAQ:ARDX) Azioni, Quote.MetaTitle.unusual-options

Ardelyx

Ardelyx Inc

ArdCoin

AnaptysBio

BioCryst Pharmaceuticals, Inc. - Common Stock

BioCryst Pharma

Celldex Therapeutics, Inc. - Common Stock

Celldex Therapeutics

CureVac

Dianthus Therapeutics, Inc. - Common Stock

Dianthus Therapeutics

Dynavax Technologies Corporation - Common Stock

Dynavax Technologies

Immunocore Holdings plc - American Depositary Shares

Immunocore Holdings

Immunome

Inhibrx Biosciences

Janux Therapeutics

MannKind

NuCana

Nurix Therapeutics

Intellia Therapeutics, Inc. - Common Stock

Intellia Therapeutics

Novavax

Oric Pharmaceuticals, Inc. - Common Stock

ORIC Pharmaceuticals

Oruka Therapeutics

Precigen

Sionna Therapeutics

Syndax Pharmaceuticals, Inc. - Common Stock

Syndax Pharmaceuticals

Stoke Therapeutics

Upstream Bio

Vera Therapeutics, Inc. - Class A Common Stock

Vera Therapeutics

Zenas BioPharma

Zymeworks

Ardelyx (ARDX) Previsione

Notizie

Utili

Quote.Nav.option-chain

Valutazioni degli analisti

Insider trading

Vendite allo scoperto

Rapporto azionario

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Comments

Ardelyx Opzioni Inusuali

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO